Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies - Xu, Linlin; Shadman, Mazyar; Flinn, Ian W.; Levy, Moshe Y.; Porter, Ryan; Burke, John M.; Zafar, Syed F.; Cultrera, Jennifer L.; Misleh, Jamal; Kingsley, Edwin C.; Yimer, Habte A.; Freeman, Benjamin; et al. (Haematologica (Roma), 2024)